Cite
HARVARD Citation
Macaluso, F. et al. (2022). Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease. Digestive and liver disease. 54 (5), pp. 629-634. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Macaluso, F. et al. (2022). Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease. Digestive and liver disease. 54 (5), pp. 629-634. [Online].